ReposiTrak (NYSE:TRAK) CEO Randall Fields Sells 3,000 Shares

by · The Cerbat Gem

ReposiTrak Inc. (NYSE:TRAK – Get Free Report) CEO Randall Fields sold 3,000 shares of the company’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $13.72, for a total value of $41,160.00. Following the transaction, the chief executive officer directly owned 187,000 shares of the company’s stock, valued at approximately $2,565,640. This represents a 1.58% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

ReposiTrak Price Performance

Shares of NYSE TRAK traded up $0.13 during midday trading on Wednesday, hitting $13.70. 163,707 shares of the company’s stock were exchanged, compared to its average volume of 54,438. The firm’s fifty day simple moving average is $14.46 and its 200-day simple moving average is $16.98. The company has a market cap of $250.57 million, a PE ratio of 38.06 and a beta of 0.39. ReposiTrak Inc. has a twelve month low of $12.75 and a twelve month high of $25.01.

ReposiTrak (NYSE:TRAK – Get Free Report) last announced its quarterly earnings results on Thursday, November 13th. The company reported $0.09 earnings per share (EPS) for the quarter. ReposiTrak had a return on equity of 14.37% and a net margin of 30.52%.The firm had revenue of $5.97 million during the quarter.

Analysts Set New Price Targets

A number of research firms recently commented on TRAK. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of ReposiTrak in a research report on Monday. Wall Street Zen downgraded shares of ReposiTrak from a “buy” rating to a “hold” rating in a research note on Friday, October 3rd. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has an average rating of “Hold”.

Check Out Our Latest Stock Analysis on TRAK

Hedge Funds Weigh In On ReposiTrak

A number of hedge funds have recently modified their holdings of TRAK. BNP Paribas Financial Markets increased its stake in ReposiTrak by 63.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock valued at $32,000 after buying an additional 634 shares during the period. Copeland Capital Management LLC purchased a new stake in shares of ReposiTrak in the third quarter valued at about $54,000. Tower Research Capital LLC TRC boosted its holdings in shares of ReposiTrak by 397.3% in the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock valued at $71,000 after acquiring an additional 2,892 shares in the last quarter. GSA Capital Partners LLP acquired a new position in shares of ReposiTrak during the third quarter worth about $219,000. Finally, R Squared Ltd purchased a new position in ReposiTrak during the second quarter worth about $235,000. 27.35% of the stock is currently owned by hedge funds and other institutional investors.

About ReposiTrak

(Get Free Report)

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

Read More